Sisi Yu

536 total citations
22 papers, 359 citations indexed

About

Sisi Yu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Sisi Yu has authored 22 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Sisi Yu's work include Cancer-related molecular mechanisms research (4 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Sisi Yu is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Sisi Yu collaborates with scholars based in China, United States and Italy. Sisi Yu's co-authors include Huaichao Luo, Min Li, Zhengyuan Luo, Zhenyu Tang, Jieqiang He, Nan Hou, Mickaël Malnoy, Lingfei Xu, Muhammad Mobeen Tahir and Fengwang Ma and has published in prestigious journals such as Scientific Reports, New Phytologist and British Journal of Pharmacology.

In The Last Decade

Sisi Yu

19 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sisi Yu China 11 161 61 61 41 39 22 359
Guangyi Jiang China 9 125 0.8× 125 2.0× 78 1.3× 54 1.3× 63 1.6× 24 328
Wentao Yang China 10 82 0.5× 68 1.1× 29 0.5× 38 0.9× 56 1.4× 44 321
Tomoaki Ito Japan 10 88 0.5× 58 1.0× 28 0.5× 100 2.4× 62 1.6× 52 266
Ye Guo China 11 97 0.6× 184 3.0× 33 0.5× 31 0.8× 111 2.8× 72 610
L Zhang China 6 104 0.6× 30 0.5× 84 1.4× 98 2.4× 90 2.3× 41 412
Etsuko Okada Japan 11 47 0.3× 113 1.9× 13 0.2× 47 1.1× 58 1.5× 47 335
Alessandra Di Sibio Italy 12 50 0.3× 46 0.8× 46 0.8× 86 2.1× 73 1.9× 33 398
Yini Ke China 13 149 0.9× 37 0.6× 19 0.3× 63 1.5× 63 1.6× 18 409
James M. Lewis United States 11 80 0.5× 209 3.4× 36 0.6× 79 1.9× 70 1.8× 31 389

Countries citing papers authored by Sisi Yu

Since Specialization
Citations

This map shows the geographic impact of Sisi Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sisi Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sisi Yu more than expected).

Fields of papers citing papers by Sisi Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sisi Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sisi Yu. The network helps show where Sisi Yu may publish in the future.

Co-authorship network of co-authors of Sisi Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Sisi Yu. A scholar is included among the top collaborators of Sisi Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sisi Yu. Sisi Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Xiaoqing, et al.. (2025). Coenzyme Q10 alleviates neurological deficits in a mouse model of intracerebral hemorrhage by reducing inflammation and apoptosis. Experimental Biology and Medicine. 250. 10321–10321.
2.
Wen, Xiaoxia, et al.. (2025). MiRNA sequencing of platelet and exosome revealed platelet miR-199b-3p as a potential biomarker in lung adenocarcinoma. Frontiers in Immunology. 16. 1619448–1619448.
3.
Chen, Bijuan, Sisi Yu, Jiali Huang, et al.. (2024). Long-term trends in the burden of nasopharyngeal carcinoma in China: A comprehensive analysis from 1990 to 2021 and projections to 2030 based on the global burden of disease study 2021. Radiotherapy and Oncology. 202. 110613–110613. 10 indexed citations
4.
Chen, Bijuan, et al.. (2024). Long-term trends and future projections of larynx cancer burden in China: a comprehensive analysis from 1990 to 2030 using GBD data. Scientific Reports. 14(1). 26523–26523. 11 indexed citations
5.
Zhang, Xingmei, Sisi Yu, Zheng‐Xiang Li, et al.. (2023). Research progress on the interaction between oxidative stress and platelets: Another avenue for cancer?. Pharmacological Research. 191. 106777–106777. 58 indexed citations
6.
Yu, Sisi, Jun Dang, Ping Wu, et al.. (2023). Prediction nomogram based on 18F-FDG PET/CT and clinical parameters for patients with diffuse large B-cell lymphoma. Annals of Hematology. 102(11). 3115–3124. 4 indexed citations
8.
Tang, Tingting, et al.. (2022). Comprehensive Analysis of miRNA-Mediated Regulatory Network and Identification of Prognosis Biomarkers in Rectal Cancer. Frontiers in Genetics. 13. 792984–792984. 6 indexed citations
10.
Zhu, Yajie, Chuan Xu, Shuya He, et al.. (2021). Not all bad: Drug-induced interstitial pneumonia in DLBCL patients is potentially fatal but could be linked to better survival. Leukemia Research. 111. 106688–106688. 4 indexed citations
11.
Yu, Sisi, Dongsheng Wang, Li Zhang, et al.. (2020). Integration of platelet features in blood and platelet rich plasma for detection of lung cancer. Clinica Chimica Acta. 509. 43–51. 11 indexed citations
12.
Li, Min, Zhengyuan Luo, Sisi Yu, & Zhenyu Tang. (2019). Proton pump inhibitor use and risk of dementia. Medicine. 98(7). e14422–e14422. 49 indexed citations
13.
Zhang, Xue, et al.. (2019). Botulinum toxin type A prevents the phenotypic transformation of fibroblasts induced by TGF‑β1 via the PTEN/PI3K/Akt signaling pathway. International Journal of Molecular Medicine. 44(2). 661–671. 22 indexed citations
14.
Bao, Xinhua, et al.. (2018). [Genetic and clinical analysis of children with early-onset epilepsy encephalopathy caused by KCNT1 gene mutation].. PubMed. 56(11). 824–828. 3 indexed citations
16.
Yu, Sisi, Huaichao Luo, Xiaoyu Song, et al.. (2017). High frequency and prognostic value of MYD88 L265P mutation in diffuse large B‑cell lymphoma with R‑CHOP treatment. Oncology Letters. 15(2). 1707–1715. 12 indexed citations
17.
Wang, Hao, et al.. (2017). Effects of RNA interference combined with ultrasonic irradiation and SonoVue microbubbles on expression of STAT3 gene in keratinocytes of psoriatic lesions. Journal of Huazhong University of Science and Technology [Medical Sciences]. 37(2). 279–285. 2 indexed citations
18.
Luo, Huaichao, Sisi Yu, Ying Lin, et al.. (2016). A novel deleterious mutation in the COMP gene that causes pseudoachondroplasia. Human Genome Variation. 3(1). 16009–16009. 2 indexed citations
19.
Yu, Sisi, et al.. (2016). Comparison of entecavir and lamivudine in preventing HBV reactivation in lymphoma patients undergoing chemotherapy: a meta-analysis. International Journal of Clinical Pharmacy. 38(5). 1035–1043. 25 indexed citations
20.
Zhang, Kaijiong, Yi Zhang, Lian Liu, et al.. (2016). [Long non-coding RNA HOTAIR in plasma as a potential biomarker for breast cancer diagnosis].. PubMed. 36(4). 488–92. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026